Lowering Blood Pressure with the Combination of a Sodium-Glucose Cotransporter 2 Inhibitor and a Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetic Patients: A Clinical Evidence.
José Carlos Arévalo-LoridoJuana Carretero GómezRicardo Gómez HuelgasDolores García de LucasLourdes Mateos PoloJosé Manuel Varela AguilarJavier Ena MuñozPublished in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2018)
The effect of a combination therapy of an iSGLT-2 and a GLP-1ra on blood pressure in a real-world setting, may have summative effects especially in SBP.